chartexchange

ELDN
Eledon Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:53 PM EST
2.03USD+2.525%(+0.05)1,137,013
Pre-marketNov 18, 2026 8:23:30 AM EST
1.92USD-3.030%(-0.06)
After-hoursNov 18, 2026 4:26:30 PM EST
1.99USD-1.970%(-0.04)
Loading…
Loading…
170.61M
Healthcare
Biotechnology
HQ
Irvine, CA, USA
Previous Close
$1.98
Beta
1.83
52-Week High
$4.49 2026-06-22
52-Week Low
$1.35 2025-11-21
SMA 50
$2.50
SMA 200
$3.12
Avg. Vol 10D
924,242
Avg. Vol 30D
929,055
Avg. Vol 90D
928,879
Relative Vol
1.22
77.79M
0.5800%
8,641
ELDN Profile

eledon pharmaceuticals, inc. is a clinical stage biotechnology company using its expertise in targeting the cd40l pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. our lead program, at-1501, is a potential best-in-class humanized igg1 anti-cd40l antibody with high affinity for cd40l, a well-validated biological target with broad therapeutic potential. the cd40/cd40l pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.

ELDN Performance
PeriodPriceDateChangeBeta
1W2.372026-11-12-14.59%1.621
1M2.162026-10-19-6.48%2.675
3M3.552026-08-19-43.10%2.324
6M3.582026-05-19-43.58%1.570
1Y1.552025-11-19+30.32%1.832
2Y3.882024-11-19-47.94%—
5Y5.312021-11-19-61.96%0.617
ELDN Stock Summary

Eledon Pharmaceuticals, Inc. Common Stock (NASDAQ:ELDN) stock price today is $2.02, and today's volume is 1,137,013. ELDN is up 2.020% today. The 30 day average volume is 929,055. ELDN market cap is $170.61M with 84.46M shares outstanding.